Targeting of the key necroptosis regulator RIPK1 or TLR4, which is known to be an inducer of the necroptosis pathway upstream of RIPK1, protects against hyperammonemia-induced liver injury and reduces circulating ammonia levels. This evidence concerns the gene RIPK1 and Hyperammonemia.